Login / Signup

Ethical Considerations for the Participation of Children of Minor Parents in Clinical Trials.

Mary A OttFrancis P CrawleyXavier Sáez-LlorensSeth Owusu-AgyeiDavid NeubauerGary DubinTatjana PoplazarovaNorman BeggSusan L Rosenthal
Published in: Paediatric drugs (2018)
Children of minor parents are under-represented in clinical trials. This is largely because of the ethical, legal, and regulatory complexities in the enrolment, consent, and appropriate access of children of minor parents to clinical research. Using a case-based approach, we examine appropriate access of children of minor parents in an international vaccine trial. We first consider the scientific justification for inclusion of children of minor parents in a vaccine trial. Laws and regulations governing consent generally do not address the issue of minor parents. In their absence, local community and cultural contexts may influence consent processes. Rights of the minor parent include dignity in their role as a parent and respect for their decision-making capacity in that role. Rights of the child include the right to have decisions made in their best interest and the right to the highest attainable standard of health. Children of minor parents may have vulnerabilities related to the age of their parent, such as increased rates of poverty, that have implications for consent. Neuroscience research suggests that, by age 12-14 years, minors have adult-level capacity to make research decisions in situations with low emotion and low distraction. We conclude with a set of recommendations based on these findings to facilitate appropriate access and equity related to the participation of children of minor parents in clinical research.
Keyphrases
  • clinical trial
  • young adults
  • healthcare
  • decision making
  • mental health
  • physical activity
  • autism spectrum disorder
  • randomized controlled trial
  • risk assessment
  • social media